Skip to main content

BD Diagnostics, Diagenode Launch BD Max Flu A/B Test in Europe

Premium

BD Diagnostics, a division of Becton Dickinson, and Belgium's Diagenode this week announced the European launch of Diagenode's influenza A and B assay for use on the BD Max molecular testing system.

The assay is the first to be commercialized through BD's partner program, under which BD has tapped a number of third-party assay developers to create a menu of in vitro diagnostic tests for the BD Max.

The new Flu A/B primers and probes recently received a CE Mark and are validated to run on the BD Max using the BD Max RNA extraction kit RNA-3 open system reagent, which "standardizes the extraction process and offers ease of use and improved laboratory workflow," BD said in a statement.

BD unveiled the new BD Max "open" system in Europe and introduced Diagenode as the first development partner in May 2011 (PCR Insider, 5/12/2011). The platform is a six-color version of the company's real-time PCR-based BD Max system that is intended to enable labs to perform both IVD and laboratory-developed tests.

BD's partnership with Diagenode also covers assays for enteric and central nervous system diseases.

Other participants in BD's partnership program include Lab21, which is developing an assay for Aspergillus fungal infections (PCR Insider, 8/4/2011), and Italy's Biodiversity, which is working on a menu of tests for infectious agents in immunocompromised patients (PCR Insider, 8/18/2011).

BD Diagnostics has not yet named any US-based assay-development partners.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.